TSNAdb: A Database for Tumor-specific Neoantigens from Immunogenomics Data Analysis
Tumor-specific neoantigens have attracted much attention since they can be used as biomarkers to predict therapeutic effects of immune checkpoint blockade therapy and as potential targets for cancer immunotherapy. In this study, we developed a comprehensive tumor-specific neoantigen database (TSNAdb...
Main Authors: | Jingcheng Wu, Wenyi Zhao, Binbin Zhou, Zhixi Su, Xun Gu, Zhan Zhou, Shuqing Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Oxford University Press
2018-08-01
|
Series: | Genomics, Proteomics & Bioinformatics |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1672022918303061 |
Similar Items
-
Neoantigens and genome instability: impact on immunogenomic phenotypes and immunotherapy response
by: Elaine R. Mardis
Published: (2019-11-01) -
Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy
by: Ravi K. Shah, et al.
Published: (2023-12-01) -
Immunogenomics and human disease /
by: Falus, Andras
Published: (2006) -
Neoantigen vaccine and neoantigen‐specific cell adoptive transfer therapy in solid tumors: Challenges and future directions
by: Yanwei Shen, et al.
Published: (2022-08-01) -
Tumor neoantigens and tumor immunotherapies
by: Wang Jiani, et al.
Published: (2024-04-01)